Jazz Pharmaceuticals Plc
(NASDAQ : JAZZ)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
Loading JAZZ News...
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
-2.41%16.1810.2%$210.07m
SHPGShire PLC Sponsored ADR
-2.24%181.290.3%$191.23m
PRGOPerrigo Co. Plc
0.40%84.414.3%$132.58m
MNKMallinckrodt Plc
-2.00%53.3811.1%$108.85m
MDCOMedicines Company
0.42%52.0619.0%$105.28m
ENDPEndo International Plc
-1.79%13.159.0%$90.85m
PRXLPAREXEL International Corporation
0.09%65.947.5%$85.48m
UTHRUnited Therapeutics Corporation
-0.50%146.7112.7%$84.75m
ICPTIntercept Pharmaceuticals, Inc.
2.81%119.1921.9%$71.58m
JAZZJazz Pharmaceuticals Plc
0.52%136.112.3%$64.77m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-0.45%123.7410.9%$47.54m
SAGESAGE Therapeutics, Inc.
-0.05%62.3012.1%$46.23m
PTLAPortola Pharmaceuticals, Inc.
4.17%33.508.8%$43.98m
HZNPHorizon Pharma plc
1.75%17.4511.1%$41.47m
SGYPSynergy Pharmaceuticals, Inc.
0.18%5.4916.1%$39.93m

Company Profile

Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products. It has a diverse portfolio of products in the areas of narcolepsy, oncology, pain and psychiatry. Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded by Bruce C. Cozadd on January 18, 2012 and is headquartered in Dublin, Ireland.